INTERBRI · CHINA MARKET ACCESS FOR MEDICAL DEVICES China-focused support. Clear scope. Accountable coordination.
Regulatory Analysis

Classification Catalogue Dynamic Adjustments Explained

7 min readClassification focus

In China, the question "which class does my device belong to?" decides whether you file or register, who reviews you and how long it takes. The starting point for that answer is the Medical Device Classification Catalogue. The catalogue is not frozen — it is adjusted dynamically as regulation and technology evolve, and a single adjustment can change a product's pathway. This article explains the mechanism, the adjustment logic, and how overseas manufacturers should respond.

1. What the catalogue is: the starting point of classification

The current Classification Catalogue is issued by the National Medical Products Administration and assigns products to risk classes. It is organised into more than twenty sub-catalogues by intended use, then subdivided into first- and second-level product categories with example product names covering the vast majority of common devices. Classification usually proceeds layer by layer: locate the sub-catalogue by intended use, then match category descriptions and examples by structure and use form.

Beside the catalogue stand classification determination documents: for products not covered or ambiguously described, the authorities clarify the management class through determination opinions. These opinions carry the same weight as the catalogue and are equally part of the classification basis.

The class decides the pathway: Class I is filed, Classes II and III are registered; foreign products submit uniformly to NMPA. Misjudging the class is one of the most expensive reworks in practice.

2. How 'dynamic adjustment' happens

The catalogue is adjusted through three main channels:

  • Catalogue adjustment announcements — authority-driven revisions of the catalogue or specific categories in response to regulatory needs and technological progress;
  • Classification determinations — case-by-case class decisions for new or ambiguous products, accumulating continuously in practice;
  • Targeted adjustments for emerging fields — new categories such as AI-based or robotic devices typically come with dedicated notices or guidance.

Adjustments do not always move products 'up': as evidence and regulatory experience mature, some products are moved from registration to filing, and vice versa. Both directions deserve attention — upgrades affect marketed and in-development products, while downgrades may open new windows in timeline and cost.

3. What adjustments mean for marketed products

After an adjustment, the immediate question is: what happens to products that already hold a filing or registration? The working principles in practice:

  • Marketed products — certificates and filings generally remain valid until expiry; but when changes, renewals or new standard requirements arise, handle them under the adjusted class and requirements;
  • In-development products — follow the adjusted catalogue; always confirm the class has not changed before submitting;
  • Pathway-switch cases — products whose class changed may need a new submission under the new pathway rather than a simple renewal of the existing credential. The transition mechanics follow the adjustment announcement and official Q&As.

Another easily missed impact is the dossier system: a class change may bring new review guidance, clinical evaluation expectations and quality-system requirements — the way you prepare the dossier must follow.

4. An action checklist for overseas manufacturers

Based on practice, we recommend institutionalising four routines:

  1. Double-check before every submission — consult the catalogue and the determination documents; if doubt remains, request a determination through the official classification system;
  2. Re-verify marketed portfolio annually — at least once a year, re-confirm class and dossier status against catalogue adjustments;
  3. Track official releases — focus on catalogue adjustment announcements and published classification determinations;
  4. Keep buffer in your timeline — pathway changes shift timeline expectations; build slack into launch plans.
A sound sequence is: catalogue first, then determination documents, then official confirmation. Never assume the class from experience or from another market.
Back to the Regulation Library